Acetone

Acetone

SCHEMBL16013121

CC(C)=O.O=C(CCc1ccccc1)OO

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.63
ALDH1A1 P00352 2/20 0.62
KMT2A Q03164 2/20 0.57
KEAP1 Q14145 1/20 0.55
FFAR1 O14842 1/20 0.52
TRPV1 Q8NER1 1/20 0.50
KDM4E B2RXH2 3/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
HDAC2 Q92769 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
MAPT P10636 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RECQL P46063 1/20 0.47
HDAC3 O15379 1/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
HDAC4 P56524 1/20 0.47
SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337736 0.94 TDP1 (0.70) TDP1ALDH1A1KMT2AKEAP1FFAR1
Butane SCHEMBL27593871 0.91 TDP1 (0.61) TDP1ALDH1A1KMT2AKEAP1FFAR1
Benzylacetone SCHEMBL27902841 0.84 ALDH1A1 (0.88) TDP1ALDH1A1KMT2AKEAP1FFAR1
SCHEMBL7364196 0.82 HDAC1 (0.64) TDP1KMT2AKEAP1NPC1RAB9A
SCHEMBL8375457 0.82 KDM4E (0.55) TDP1ALDH1A1KMT2AKDM4ENPC1
SCHEMBL466545 0.81 TDP1 (0.63) TDP1ALDH1A1KMT2AKEAP1FFAR1
Methyl 3-Phenylpropanoate SCHEMBL17748824 0.81 TDP1 (0.63) TDP1ALDH1A1KMT2AKEAP1FFAR1
SCHEMBL26927562 0.81 MAPT (0.63) TDP1KMT2ANPC1RAB9AHDAC2
Methyl 3-Phenylpropanoate SCHEMBL168711 0.80 TDP1 (0.68) TDP1ALDH1A1KMT2AKEAP1FFAR1
SCHEMBL8376797 0.80 KDM4E (0.52) TDP1KMT2AKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964212-A1 CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS Aventis Pharma S.A. (FR) 2016-01-13 EP disclosed
WO-2014135524-A1 CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS AVENTIS PHARMA S.A. (FR) 2014-09-12 WO disclosed